Literature DB >> 20445005

Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population.

Patricia Colque-Navarro1, Gunnar Jacobsson, Rune Andersson, Jan-Ingmar Flock, Roland Möllby.   

Abstract

Serum samples from 151 healthy individuals aged from 15 to 89 years were investigated by enzyme-linked immunosorbent assay (ELISA) for IgG levels against 11 different purified antigens from Staphylococcus aureus. Surface antigens, such as teichoic acid, clumping factors A and B, and bone sialoprotein binding protein, and extracellular proteins, such as alpha-toxin, lipase, enterotoxin A, toxic shock syndrome toxin, scalded-skin syndrome toxin, fibrinogen binding protein, and extracellular adherence protein, were used. The IgG values were analyzed in relation to the state of nasal carriage at the time of sampling. There was great individual variation in antibody levels in both young and elderly healthy subjects. Occurrence of S. aureus in the nares at the time of sampling was correlated with higher antibody levels, while elderly individuals over 65 years of age showed slightly lower levels than younger adults. More individuals than was expected from random probability calculations showed high antibody levels against several antigens, and more individuals than would be expected showed low levels against several antigens. Certain extracellular proteins had more often induced IgG levels of the same magnitude in the same individuals, indicating that among these individuals, there was a tendency to respond to certain antigens in the same way. Most individuals had circulating IgG antibodies to the 11 tested antigens, and some individuals had the tendency to be "good responders" to several antigens, while others were "poor responders." These findings constitute basic knowledge for the development of improved serological diagnostics, immune prophylaxis, individual prognosis tools, and therapy against invasive Staphylococcus aureus infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445005      PMCID: PMC2897265          DOI: 10.1128/CVI.00506-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  31 in total

1.  A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family.

Authors:  H s Tung; B Guss; U Hellman; L Persson; K Rubin; C Rydén
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Antibody responses in patients with invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; P Colque-Navarro; E Gustafsson; R Andersson; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-10       Impact factor: 3.267

3.  Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein.

Authors:  P Colque-Navarro; M Palma; B Söderquist; J I Flock; R Möllby
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

4.  Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

Authors:  C von Eiff; K Becker; K Machka; H Stammer; G Peters
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

Review 5.  Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power.

Authors:  Herminia de Lencastre; Duarte Oliveira; Alexander Tomasz
Journal:  Curr Opin Microbiol       Date:  2007-10-24       Impact factor: 7.934

6.  More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation.

Authors:  Muzaffar Hussain; Axana Haggar; Georg Peters; Gursharan S Chhatwal; Mathias Herrmann; Jan-Ingmar Flock; Bhanu Sinha
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

7.  Antibodies to Staphylococcus aureus bone sialoprotein-binding protein indicate infectious osteomyelitis.

Authors:  Lena Persson; Christian Johansson; Cecilia Rydén
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

8.  Reclassification of Staphylococcus aureus nasal carriage types.

Authors:  Alex van Belkum; Nelianne J Verkaik; Corné P de Vogel; Hélène A Boelens; Jeroen Verveer; Jan L Nouwen; Henri A Verbrugh; Heiman F L Wertheim
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

9.  Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.

Authors:  Nelianne J Verkaik; Corné P de Vogel; Hélène A Boelens; Dorothee Grumann; Theo Hoogenboezem; Cornelis Vink; Herbert Hooijkaas; Timothy J Foster; Henri A Verbrugh; Alex van Belkum; Willem J B van Wamel
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

10.  Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans.

Authors:  Heiman F L Wertheim; Evelyn Walsh; Roos Choudhurry; Damian C Melles; Hélène A M Boelens; Helen Miajlovic; Henri A Verbrugh; Timothy Foster; Alex van Belkum
Journal:  PLoS Med       Date:  2008-01-15       Impact factor: 11.069

View more
  34 in total

1.  Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.

Authors:  Batu K Sharma-Kuinkel; Yuling Wu; David E Tabor; Hoyin Mok; Bret R Sellman; Amy Jenkins; Li Yu; Hasan S Jafri; Thomas H Rude; Felicia Ruffin; Wiley A Schell; Lawrence P Park; Qin Yan; Joshua T Thaden; Julia A Messina; Vance G Fowler; Mark T Esser
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

Review 2.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

3.  Identification of preexisting adaptive immunity to Cas9 proteins in humans.

Authors:  Carsten T Charlesworth; Priyanka S Deshpande; Daniel P Dever; Joab Camarena; Viktor T Lemgart; M Kyle Cromer; Christopher A Vakulskas; Michael A Collingwood; Liyang Zhang; Nicole M Bode; Mark A Behlke; Beruh Dejene; Brandon Cieniewicz; Rosa Romano; Benjamin J Lesch; Natalia Gomez-Ospina; Sruthi Mantri; Mara Pavel-Dinu; Kenneth I Weinberg; Matthew H Porteus
Journal:  Nat Med       Date:  2019-01-28       Impact factor: 53.440

Review 4.  Live-Animal Epigenome Editing: Convergence of Novel Techniques.

Authors:  J Antonio Gomez; Ulrika Beitnere; David J Segal
Journal:  Trends Genet       Date:  2019-05-22       Impact factor: 11.639

5.  Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?

Authors:  Min Qiu; Zachary Glass; Qiaobing Xu
Journal:  Biomacromolecules       Date:  2019-08-07       Impact factor: 6.988

6.  Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus.

Authors:  H Ghasemzadeh-Moghaddam; W van Wamel; A van Belkum; R A Hamat; V K Neela
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-04       Impact factor: 3.267

7.  Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectin.

Authors:  Kenji Kurokawa; Dong-Jun Jung; Jang-Hyun An; Katharina Fuchs; Yu-Jin Jeon; Na-Hyang Kim; Xuehua Li; Koichiro Tateishi; Ji Ae Park; Guoqing Xia; Misao Matsushita; Kazue Takahashi; Hee-Ju Park; Andreas Peschel; Bok Luel Lee
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

8.  Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.

Authors:  Jong-Ho Lee; Na-Hyang Kim; Volker Winstel; Kenji Kurokawa; Jesper Larsen; Jang-Hyun An; Adnan Khan; Min-Young Seong; Min Ja Lee; Paal Skytt Andersen; Andreas Peschel; Bok Luel Lee
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

9.  Prevalence of enterotoxin genes in Staphylococcus aureus colonising food handlers: does nasal carriage status matter?

Authors:  J Ho; M Boost; M O'Donoghue
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-26       Impact factor: 3.267

Review 10.  Investigational drugs to treat methicillin-resistant Staphylococcus aureus.

Authors:  Cuong Vuong; Anthony J Yeh; Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Investig Drugs       Date:  2015-11-04       Impact factor: 6.206

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.